Performance-Enhancing Substances
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: healthy volunteers; of both genders; older than 18 years; impeded in their cycling training programs for at least 12 months; conduct at least four MTB training schools per week.
Exclusion criteria
Exclusion criteria: make use of supplements with a potential stimulating effect on the cardiovascular system (such as caffeine and guarana powder); history of current injuries or in the last six months; not willing to abstain from intense exercise 24 hours before the test
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The oral formulation of HPß-CD-Angiotensin- (1-7) (1.75 mg) improved the physical performance of MTB athletes submitted to a progressive load protocol until voluntary fatigue in a leg cycle ergometer, since it promoted an increase maximum oxygen consumption (+6 mlo2.kg-1.min-1 in supplemented condition) assessed by ergospirometry (vo2000), a longer total exercise time (+60 seconds in supplemented condition);The oral formulation of HPß-CD-Angiotensin- (1-7) (1.75 mg) improved the physical performance of MTB athletes submitted to a progressive load protocol until voluntary fatigue in a leg cycle ergometer, since it promoted less subjective perception of effort (assessed using the Borg scale) (- 3pts). There was no difference in cardiovascular parameters (BP and HR) between placebo and the condition treated at rest or at peak physical effort. | — |
Countries
Brazil